Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.91
16.96
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Shandong Sinobioway Biomedicine Co Ltd
Cash from Financing Activities
Shandong Sinobioway Biomedicine Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
|
Cash from Financing Activities
-¥194.9m
|
CAGR 3-Years
36%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-10%
|
|
|
Fufeng Group Ltd
HKEX:546
|
Cash from Financing Activities
¥1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
G
|
GHW International
HKEX:9933
|
Cash from Financing Activities
-¥5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
|
Cash from Financing Activities
¥6.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
|
Cash from Financing Activities
¥1.2B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
A
|
Anhui Jinhe Industrial Co Ltd
SZSE:002597
|
Cash from Financing Activities
-¥204.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Shandong Sinobioway Biomedicine Co Ltd
Glance View
Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 653 full-time employees. The company went IPO on 2011-05-20. The firm's main products include encyclopedia, anferon, triethyl orthoformate, trimethyl orthofomate, trimethyl orthoacetate and related secondary products, among others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Shandong Sinobioway Biomedicine Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-194.9m
CNY
Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Cash from Financing Activities amounts to -194.9m CNY.
What is Shandong Sinobioway Biomedicine Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-10%
The average annual Cash from Financing Activities growth rates for Shandong Sinobioway Biomedicine Co Ltd have been 36% over the past three years , 14% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
